Avadel to Present Data on Lumryz for Narcolepsy at SLEEP 2024

At SLEEP 2024, Avadel will present new data on Lumryz, the first extended-release, once-nightly formulation of sodium oxybate for narcolepsy.

Related Keywords

Houston ,Texas ,United States ,Michaelj Thorpy ,Maggie Lavender ,Jennifer Gudeman ,Drug Administration ,Wake Disorders Center At Montefiore ,Avadel Pharmaceuticals ,Georger Brown Convention Center ,Medicine Associates ,Risk Evaluation ,Mitigation Strategy ,Comprehensive Sleep Medicine Associates ,Sleep Wake Disorders Center ,Albert Einstein College ,